Periotherapia

Osaka, Japan

Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.

$6.8M raised

May 2026

Grant

Alternative Medicine Personal Health Therapeutics

Top Investors

Mitsubishi UFJ Capital Osaka University Venture Capital Chushin Venture Capital AMED Techno Science

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Periotherapia

How much funding has Periotherapia raised?

Periotherapia has raised $6.8M in total funding. The most recent round was Grant. The last funding was announced in May 2026.

Who are Periotherapia's investors?

Periotherapia's investors include Mitsubishi UFJ Capital, Osaka University Venture Capital, Chushin Venture Capital, AMED, Techno Science.

Where is Periotherapia headquartered?

Periotherapia is headquartered in Osaka, Japan.

What does Periotherapia do?

Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.

What stage is Periotherapia at?

Periotherapia is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"Periotherapia — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/periotherapia. Accessed July 2, 2026.

APA

VCBacked. (2026). Periotherapia — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/periotherapia

Wikipedia (cite web)

{{cite web |title=Periotherapia — Funding & Investors |url=https://www.vcbacked.co/company/periotherapia |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.

Similar Companies in Alternative Medicine

Red Arrow Therapeutics